A genetic test known as chromosomal microarray analysis (CMA) could help identify the cause of sudden infant death syndrome (SIDS) or its counterpart in older children, known as sudden unexplained ...

Chromosomal microarray analysis, a two-year-old gene-chip technology used to look for potential genetic abnormalities in children, has proved to be remarkably sensitive in detecting abnormalities ...

Chromosomal microarray technology provides info on fetus Doctor: "It's an evolving technology" More insurers cover test, which costs about $1,500 WESTCHESTER, N. Y. -- A new test, called ...

Explore the booming Chromosomal Microarray Market, projected to grow from USD 1.69 Billion in 2025 to USD 3.32 Billion by 2034, at a 10.2% CAGR. Driven by demand for advanced genetic diagnostics ...

We undertook genome-wide chromosomal microarray analysis (CMA) of 202 adults with idiopathic ID recruited from community and in-patient ID psychiatry services across England.

Chromosomal microarray analysis, a two-year-old gene-chip technology used to look for potential genetic abnormalities in children, has proved to be remarkably sensitive in detecting abnormalities ...

A large, multi-center clinical trial led by researchers from Columbia University Medical Center shows that a new genetic test resulted in significantly more clinically relevant information than ...

For example, chromosomal microarray analysis (CMA) is considered the gold standard for cytogenetic analysis, providing critical insight into potentially significant variants of interest and faster ...